TY  - GEN
AU  - Chica-Parrado, María Rosario
AU  - Godoy-Ortiz, Ana
AU  - Jiménez, Begoña
AU  - Ribelles, Nuria
AU  - Barragan, Isabel
AU  - Alba, Emilio
PY  - 2020
DO  - 10.3390/cancers12082012
UR  - http://hdl.handle.net/20.500.12105/18080
AB  - Neoadjuvant Chemotherapy (NAC) in Breast Cancer (BC) has proved useful for the reduction in tumor burden prior to surgery, allowing for a more extensive breast preservation and the eradication of subjacent micrometastases. However, the impact on...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - Breast cancer
KW  - Neoadjuvant chemotherapy
KW  - Pathological complete response
KW  - Predictive markers
KW  - Residual disease
KW  - Neoplasias de la mama
KW  - Terapia neoadyuvante
KW  - Trastuzumab
KW  - Receptor, erbB-2
KW  - Neoadjuvant Therapy
KW  - Prognosis
KW  - Tumor Burden
KW  - Breast Neoplasms
KW  - Neoplasm Micrometastasis
KW  - Antibodies, Monoclonal, Humanized
KW  - Gene Expression
KW  - Recurrence
KW  - Mutation
KW  - Humans
KW  - Female
TI  - Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors
TY  - review article
ER  -